Immunity (Cell Press) 'Under Review': What Each Status Means
If your Immunity submission shows Under Review, here is what Cell Press editors are doing during each stage and when to follow up.
While you wait
Waiting on Immunity? Get your next move ready.
The Immunity wait is out of your hands; the next move isn't. Scan your next manuscript free, or run this paper through the scan to see what reviewers typically push back on, so the revision response is ready when the decision lands.
Immunity review timeline: what the data shows
Time to first decision is the most actionable number. What happens after varies by manuscript and reviewer availability.
What shapes the timeline
- The guide lists 3-5 days for desk decisions; check its source and reporting period before using it for planning.
- Editorial assignment, reviewer availability, topic, and revisions can all affect elapsed time.
- Revision and additional experiments can extend the timeline; the decision letter supplies the actual revision deadline.
What to do while waiting
- Track the record in the submission portal; a status label alone does not prove external review has begun.
- Follow the journal's status-inquiry guidance and any deadline in its correspondence.
- Prepare revision materials in parallel if you expect a revise-and-resubmit decision.
Acceptance rate: Elsevier's journal catalog lists a 13% acceptance rate for Immunity (read October 2026). That is a journal-wide figure, not the odds for any one manuscript. Elsevier journal catalog.
Last reviewed: 2026-05-16.
Quick answer: If your Immunity submission shows "Under Review," elapsed time is the most reliable signal. Immunity has a 2025 Journal Impact Factor of 30.6 in the 2026 JCR release, and Cell Press lists 7 days from submission to first editorial decision for Immunity (per Cell Press editorial guidance for Immunity).
Accepted papers are published within 10 weeks of acceptance. Manuscripts invited for revisions have a 2 to 3 month revision timeline.
For a second opinion before reviewers see your manuscript, run a Immunity submission readiness check.
Submission portal and editorial contact: Immunity uses Cell Press Editorial Manager at Editorial Manager submission portal. Editorial questions go to immunity@cell.com, referencing the manuscript ID. The Cell Press author status portal covers status-check guidance across all Cell Press titles. Tip: Immunity uniquely accepts presubmission inquiries with 2 to 5 business day feedback when scope is uncertain.
How Cell Press handles an Immunity submission
Immunity operates the Cell Press consulting editor model. The consulting editor reads the entire paper and evaluates immunology mechanism depth, broad-immunology audience fit, and orthogonal-method validation. Cell Press's editorial guidance for Immunity emphasizes that submitted articles are reviewed for both technical excellence and general interest.
The general-interest threshold at Immunity is high.
Cell Press editorial culture at Immunity is decisive: most rejections happen at the consulting editor read, within days of submission. Authors who pass the consulting editor stage have cleared the steepest filter at Cell Press.
What is Immunity's review pipeline?
Status | What is happening |
|---|---|
Submitted | Administrative processing at Cell Press editorial office |
With Editor | Consulting editor evaluating desk-screen fit and immunology scope |
Editor Discussion | Internal Cell Press editor consultation for ambiguous fit cases |
Under Review | External reviewers invited or actively reviewing |
Required Reviews Complete | Consulting editor synthesizing reports |
Decision Pending | Editor finalizing recommendation letter |
Decision Sent | Reject, R&R, or accept |
Should Immunity authors use a presubmission inquiry?
Immunity uniquely supports presubmission inquiries. Authors uncertain about scope can submit an abstract to Immunity and receive feedback within 2 to 5 business days about whether the work is suitable for the journal. This is particularly valuable for translational immunology work where the boundary between Immunity, Cell Reports Medicine, and JCI is unclear. A "yes" response to a presubmission inquiry significantly shortens the desk-screen risk during full submission.
What happens at the Immunity consulting editor desk screen?
Before the paper reaches external reviewers, a Cell Press consulting editor at Immunity evaluates whether the immunology mechanism warrants Immunity's selective editorial slots. Cell Press lists 7 days from submission to first editorial decision for Immunity. A desk rejection most often means the consulting editor concluded that the work would fit better at a sister Cell Press title (Cell Reports, Cell Reports Medicine, iScience) or that the broad-immunology audience fit is uncertain.
What happens at administrative processing at Immunity?
The Cell Press editorial office confirms files are complete: manuscript with figures embedded, supplementary information separate, reporting checklists where applicable (ARRIVE for animal work, MIQE for quantitative PCR, CONSORT for any clinical-trial component, STROBE for observational immunology studies), STAR Methods compliance documentation, cover letter directed to the editor, conflict-of-interest declarations, and ethics-statement documentation including IACUC and IRB approvals.
What happens at the consulting editor desk screen at Immunity?
The consulting editor reads the paper and evaluates immunology mechanism depth, broad-immunology audience fit, and whether orthogonal-method validation supports the central claim.
What happens if Immunity editors discuss fit?
In parallel with the consulting editor's primary read, ambiguous-fit papers are discussed at the Cell Press editor meeting where peer consulting editors at sister Cell Press titles weigh in on whether the paper would fit better at Immunity, Cell Reports, or Cell Reports Medicine. This editorial-team discussion runs alongside the desk-screen and is not visible to the author.
What happens during Immunity reviewer recruitment?
Cell Press consulting editors at Immunity typically invite two to three external reviewers. Recruitment can take a while because immunology reviewers with topic-matched expertise (e.g., innate-immunity mechanism + clinical translation, T-cell biology + structural immunology) are scarce. Reviewer invitations from Cell Press are weighted higher than most Elsevier titles.
What happens during Immunity active peer review?
Once reviewers agree to review, they return reports on their own schedules. Reviewers are asked to evaluate mechanism depth, orthogonal-method validation, broad-immunology framing, and reproducibility. Reviewer reports for Immunity tend to be thorough.
What happens after reviewer reports at Immunity?
After both reports return, the consulting editor synthesizes them. Manuscripts invited for revisions have a 2 to 3 month revision timeline; accepted papers are published within 10 weeks of acceptance per Cell Press editorial guidance.
When to worry
- Rejection in the first days: Administrative issue or immediate scope mismatch.
- Rejection before reviewers are assigned: Consulting editor desk rejection. Most rejections happen here.
- Still Under Review after 2 weeks: Strong signal. Paper passed the steepest Cell Press filter.
- Still Under Review after 8 weeks: Reviewer-recruitment or reviewer-report delay. A polite inquiry to immunity@cell.com is appropriate.
- Status changes to "Decision Pending": Reports are in and the editor is preparing the decision.
"My paper has been Under Review for 4 weeks. Is that bad?"
This is the most common anxiety we hear from Immunity authors during the active editorial window. The honest answer: no, four weeks without a decision is not a sign of a problem. Reports may already be in editorial synthesis with the consulting editor preparing a recommendation. The 4-week mark is typically NOT a worry signal at Immunity. Most reviewer-driven delays come from reviewer-recruitment timing rather than slow reviews.
If the portal still says Under Review at the 6-week mark, the most likely explanation is reviewer extension granted by the consulting editor. This is normal practice at Cell Press.
What you should NOT do during the 4-to-6-week window is email the editorial office. Cell Press consulting editors at Immunity are managing 40+ active papers; an inquiry at 4 weeks adds friction without accelerating the timeline.
What to do while waiting
- Do not email the editorial office during the first 8 weeks unless an urgent ethics issue surfaces.
- Do not submit the paper anywhere else while it is Under Review at Immunity. Cell Press has explicit prohibitions on dual submission.
- Prepare a point-by-point response template for likely reviewer concerns: orthogonal-method validation, broad-immunology framing, in-vivo or clinical translation depth.
- If you have related work submitted elsewhere or recently published, prepare disclosure language for when revisions are requested.
- Read recent Immunity papers in your subfield to calibrate the current editorial bar.
Readiness check
While you wait on Immunity, scan your next manuscript.
The scan takes about 2 to 3 minutes. Use the result to decide whether to revise before the decision comes back.
If Immunity rejects: sister-journal cascade with reasoning
If your Immunity paper is rejected after review, the natural cascade depends on what the reviewers and consulting editor cited:
Cell Reports is the most natural Cell Press cascade because Cell Press editors transfer manuscripts directly via the portable peer-review system, preserving reviewer reports for the receiving editor. Cell Reports has a broader scope; papers rejected from Immunity for broad-audience reasons often fit Cell Reports cleanly. Cell Press carries the reviewer reports across.
Cell Reports Medicine is a secondary cascade option for translational immunology papers where the clinical-translation framing is stronger than the basic-immunology mechanism. Cell Reports Medicine accepts both basic and translational work but weights clinical relevance more heavily.
Nature Immunology is a cascade option for papers where the broader immunology framing is stronger than the mechanism specificity, particularly for systems-immunology or cell-fate papers. Nature Immunology operates separately from Cell Press but accepts manuscripts at a comparable bar.
How Immunity compares to nearby alternatives
Feature | Immunity | Cell Reports | Nature Immunology | Science Immunology |
|---|---|---|---|---|
Time to first decision | Cell Press lists 7 days | Not listed | Not listed | Not listed |
Reviewer count | 2 to 3 | 2 to 3 | 2 to 3 | 2 to 3 |
Peer-review model | Cell Press transparent (optional) | Cell Press transparent (optional) | Nature transparent (optional) | Standard |
Editorial bar | Top immunology mechanism + broad audience | Mechanistic + broad biology, faster | Top immunology, broad significance | Science-tier immunology |
Submit If
If your Immunity paper is Under Review past 1 week, you have cleared the consulting editor screen at Cell Press. Use the waiting window to prepare a thorough revision response template.
Immunity submission readiness check takes about 5 minutes.
Think Twice If
Cell Press consulting editors at Immunity retain discretion to reject after partial review if reviewer reports surface mechanism or broad-audience concerns the desk screen did not catch. Approximately 25 percent of papers sent for peer review at Immunity are accepted, meaning 75 percent of post-desk-screen papers still receive a reject decision.
- Your mechanism rests on one knockout, antibody depletion, inhibitor, or omics association without an orthogonal rescue, perturbation, cellular readout, or in-vivo confirmation.
- Your first figure and abstract stay inside one cell type, pathogen, tissue, or disease context without naming the broader immunology principle.
- Your STAR Methods package omits antibody clone/catalog numbers, flow cytometry gating, raw FCS or imaging deposits, animal strain/sex details, or key resource identifiers.
Check whether your Immunity mechanism claim is visible →
Check if your Immunity orthogonal-validation package is reviewer-ready →
Check your Immunity Cell Press routing plan →
For a pre-upload diagnostic of mechanism depth and broad-immunology framing, run a Immunity pre-submission diagnostic before reviewer reports surface those concerns.
Immunity Status Inquiry Checklist
- [ ] Confirm the manuscript ID, original submission date, and last Editorial Manager status-change date.
- [ ] Compare elapsed time with the Immunity review-time guide before deciding whether the wait is outside the normal Cell Press window.
- [ ] Recheck orthogonal validation, STAR Methods, Key Resources Table, flow cytometry gating, antibody details, raw-data deposits, and cover-letter framing.
- [ ] Prepare a polite inquiry only after the normal review window has passed, and include the manuscript ID.
This guide tells you what Immunity editors look for while a manuscript is Under Review. The review tells you whether your paper passes the mechanism-depth, orthogonal-validation, STAR Methods, and Cell Press routing checks before reviewers turn those gaps into revision demands. Manusights has reviewed 50+ immunology and Cell Press-targeted manuscripts, offers a 60-day money-back guarantee on paid reviews, and we do not train AI on private author manuscripts.
Last verified: Immunity author guidance at Cell Press author instructions and Cell Press editorial documentation.
The Immunity reviewer experience
Cell Press asks reviewers at Immunity to evaluate four things specifically. The table below maps each to actionable preparation.
Reviewer focus area | What Immunity asks reviewers to evaluate | How to prepare for it |
|---|---|---|
Mechanism depth | Is the immunology mechanism established with cellular, molecular, or in-vivo resolution? | Include perturbation experiments (genetic knockout, antibody depletion, conditional alleles). Cell Press explicitly weighs whether mechanism work uses orthogonal-method validation. |
Orthogonal validation | Do at least two independent approaches confirm the central claim? | Pair genetic perturbation with antibody-based readout; pair in-vitro with in-vivo phenotyping. Single-approach mechanism papers face higher reviewer skepticism. |
Broad immunology framing | Does the work travel beyond one immunology subfield to broader immunology audiences? | Frame the introduction around a broader-immunology principle the findings illuminate. STAR Methods compliance is required for Cell Press. |
Reproducibility | Could another lab reproduce the central experiments with the methods as written? | Use STAR Methods format (required at Cell Press). Deposit raw flow cytometry data, original images, and code. Detail antibody catalog numbers and clone identifiers. |
What we see in our pre-submission review work on Immunity manuscripts
Across Immunity manuscripts, and across Manusights review data from 50+ immunology and Cell Press-targeted manuscripts, three patterns generate the most consistent reviewer concerns we see at Immunity. These patterns matter because an Under Review status often means the consulting editor saw a plausible top-immunology story, but reviewers are now testing whether the manuscript components prove mechanism, scope, and reproducibility.
Single-method mechanism without orthogonal confirmation. When the central immunology mechanism rests on one experimental approach, such as only conditional knockout, only antibody depletion, only inhibitor treatment, or only an omics association, Immunity reviewers consistently request a second orthogonal validation. The strongest manuscripts pair perturbation with rescue, in-vivo phenotyping, cellular readouts, or independent molecular assays before submission.
Narrow immunology framing flagged for broad-audience fit. When the introduction frames the work too narrowly around one cell type, one pathogen, one tissue, or one disease context, broad-immunology framing concerns surface from at least one Immunity reviewer. The strongest manuscripts make the broader immunology principle visible in the title, abstract, first figure, and final introduction paragraph, not only in the discussion.
Cell Press venue mismatch flagged by consulting editor. When the consulting editor concludes the work is sound but the broad-immunology audience appeal is uncertain, transfer offers to Cell Reports or Cell Reports Medicine are common. Authors should consider a presubmission inquiry to clarify fit before full submission and should keep reviewer-response language portable enough to reuse inside the Cell Press transfer system.
We also check whether the figure legends, Key Resources Table, and cover letter reinforce the same mechanism claim, because Immunity reviewers often notice when the narrative is stronger than the validation package.
Source limitation: this guidance combines official guidance, public status and timing signals, and anonymized Manusights pre-submission review patterns; it does not use private Cell Press editorial records. Compared with official guidance, the useful reader-facing value is translating the status into mechanism, orthogonal-validation, STAR Methods, cover-letter, and Cell Press routing checks authors can act on while waiting.
Methodology note
This page was created from Cell Press's public author guidance at Cell Press author instructions, Cell Press's published time to first editorial decision for Immunity, and Manusights pre-submission review experience with Immunity-targeted manuscripts.
What to read next
For the Cell Press immunology landscape beyond Immunity, start with the Immunity journal overview, the Immunity submission guide, the Immunity review-time guide, and the Immunity cover-letter guide.
Then compare Cell Reports (broader scope, faster turnaround, Cell Press portable peer-review transfer), Cell Reports Medicine (clinical-translation focus), Cell Host & Microbe, and iScience (open-access alternative across Cell Press). The choice across these titles depends on whether the central contribution is mechanism-depth-with-broad-audience (Immunity), broader biology (Cell Reports), host-microbe immunology (Cell Host & Microbe), translational-clinical (Cell Reports Medicine), or open-access (iScience).
For technical issues during Cell Press submission, the editorial office at immunity@cell.com handles most queries via the manuscript record.
Reviewers at Immunity typically draw from one mechanism-focused immunology expert and one broader-cell-biology or clinical-translation specialist. Preparing a response template that addresses both perspectives accelerates revision rounds substantially.
For a pre-upload check of your manuscript against the Immunity mechanism-depth-plus-broad-audience bar before submission, our Immunity pre-submission diagnostic flags the orthogonal-validation gaps and narrow-framing weaknesses most likely to surface in reviewer reports.
Frequently asked questions
Your manuscript has cleared Cell Press Editorial Manager admin checks and is being evaluated. The status covers everything from the consulting editor's first read through external reviewer reports. Cell Press editors are evaluating immunology mechanism depth, orthogonal-method validation, and broad immunology audience fit. Approximately 25 percent of papers sent for peer review are accepted at Immunity.
Cell Press lists 7 days from submission to first editorial decision for Immunity. Manuscripts invited for revisions have a 2 to 3 month revision timeline. Submitted articles are reviewed for both technical excellence and general interest, and those that are accepted are published within 10 weeks of acceptance.
Wait at least 8 weeks before inquiring. Contact immunity@cell.com referencing the manuscript ID. Cell Press consulting editors prefer email contact over portal-only messages.
No. Four weeks without a decision is not a sign of a problem for a paper that went out for review. Reports may already be in editorial synthesis.
Yes, when scope is uncertain. Immunity accepts presubmission inquiries and provides feedback within 2 to 5 business days. This helps determine suitability before submitting a full manuscript and saves time if the work is scope-mismatched.
Your paper passed the consulting editor desk screen and at least two reviewers have agreed to review. Cell Press operates a transparent peer-review system where reviewer reports can be published alongside the accepted paper if the author opts in.
Yes. Reviewer recruitment and revision rounds set the pace once a paper is out for review.
Past 8 weeks is the right moment for a polite inquiry. Past 12 weeks suggests a reviewer dropped out and the consulting editor needs a replacement. Silence in the first 4 weeks is normal at Cell Press.
Sources
Free guide
Waiting is not the same as being ignored, and there is a way to tell.
Reviewers usually get ten days. When it has been months, an appeal and a complaint are different instruments with different addresses, and only one of them fits a delay. This is which to use, and the wording that gets an answer.
Final step
Done interpreting the status? Put the wait to work.
The Immunity decision will arrive on the journal's clock. What you control is what's next: scan your next manuscript free, or run this paper through the scan so the likely reviewer pushback is mapped before the revision request lands.
Free scan, no card needed.
Target journal Immunity
Private API processing. Your manuscript is not used to train models.
Re-read the status guidePut the guidance to work
Turn a decision into a clear next step.
Use the practical response workflow when a manuscript needs revision, or the process guide when you need to understand what the editorial status means.